Loading…
FOLIC ACID is a brand name for Folic Acid. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Folic Acid is indicated for the prevention of first occurrence neural tube defects in the foetus. For use by women who are planning a pregnancy.
Verbatim from this product's MHRA label. Tap a section to expand.
4mg) daily. 4 mg) daily prior to conception and be continued for at least the first 12 weeks of pregnancy. Method of administration Oral. The tablets should be swallowed with water.
Folic acid is generally well tolerated. Rare (≥1/10,000 to <1/1,000) Not known (cannot be estimated from the available data) Gastrointestinal disorders Anorexia, nausea, abdominal distension and flatulence Immune system disorders Allergic reactions, comprising erythema, rash, pruritus, urticaria, dyspnoea.
anaphylactic reactions Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Folic acid should not be administered for treatment of pernicious anaemia or undiagnosed megaloblastic anaemia without sufficient amounts of cyanocobalamin (vitamin B12) as folic acid alone will not prevent and may precipitate development of subacute combined degeneration of the spinal cord.
Therefore a full clinical diagnosis should be made before initiating treatment. Women with pre-existing diabetes, obesity, family history of neural tube defects, or previous pregnancy affected by neural tube defect have an increased risk of having a pregnancy affected by a neural tube defect and higher doses should be considered.
Folic Acid Tablets contain sodium This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
1. Folic acid should not be given alone in the treatment of Addisonian pernicious anaemia and other vitamin B12 deficiency states, as this may precipitate the onset of subacute combined degeneration of the spinal cord. Patients with malignant disease, unless megaloblastic anaemia due to folic acid deficiency.
Should not be taken by people with folate dependant tumours.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Folic Acid in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.